Admenta® 10 contains memantine hydrochloride, an N-methyl-D-aspartate (NMDA) receptor antagonist that helps regulate the activity of glutamate, an important neurotransmitter involved in learning and memory. By reducing excessive glutamate-mediated stimulation, memantine may help protect neurons from excitotoxic damage while supporting normal cognitive function.

The medication is primarily indicated for the treatment of moderate to severe Alzheimer's disease and may help improve cognition, memory, attention, and the ability to perform activities of daily living. In selected clinical situations, healthcare professionals may prescribe memantine for other neurological conditions based on individual patient needs and clinical judgment.

Memantine is generally well tolerated and can be used alone or in combination with acetylcholinesterase inhibitors when clinically appropriate. Treatment decisions, dosing schedules, titration, and duration of therapy should always be determined by a qualified healthcare professional.